Herpes zoster in patients with drug-induced hypersensitivity syndrome/DRESS

Acta Dermato-Venereologica

Volumn 92, Issue 2, 2012, Pages 206-207

  Kano, Yoko ^a   Horie, Chiho ^a   Inaoka, Miyuki ^a   Tadashi, Ishida ^a   Mizukawa, Yoshiko ^a   Shiohara, Tetsuo ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALLOPURINOL; CARBAMAZEPINE; CORTICOSTEROID; COTRIMOXAZOLE; LAMOTRIGINE; LOXOPROFEN; MEXILETINE; PHENOBARBITAL; PHENYTOIN; SALAZOSULFAPYRIDINE;

ADULT; AGED; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DRESS SYNDROME; ERYTHEMA; FEMALE; FOLLOW UP; HERPES ZOSTER; HUMAN; HUMAN HERPESVIRUS 6; LETTER; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

ACYCLOVIR; ADRENAL CORTEX HORMONES; ADULT; AGED; ANTIBODIES, VIRAL; ANTICONVULSANTS; ANTIVIRAL AGENTS; DRUG HYPERSENSITIVITY; EOSINOPHILIA; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; VIRUS ACTIVATION;

EID: 84859625163     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1317     Document Type: Letter

References (15)

1. Descamps V, Bouscarat F, Laglenne S, Aslangul E, Veber B, et al. Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol 1997; 137: 605-608.
2. Suzuki Y, Inagi R, Aono T, Yamashita K, Shiohara T. Human herpesvirus 6 infection as a risk factor of the development of severe drug-induced hypersensitivity. Arch Dermatol 1998; 134: 1108-1112.
3. Descamps V, Mahe E, Houhou N, Abramowitz L, et al. Druginduced hypersensitivity syndrome associated with Epstein-Barr virus infection. Br J Dermatol 2003; 148: 1032-1034.
4. Picard D, Janela B, Descamps V, D'Incan M, Courville P, Jacquot S, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Sci Transpl Med 2010; 25: 45ra62.
5. Mitani N, Aihara M, Yamakawa Y, Yamada M, Itoh N, Mizuki N, et al. Drug-induced hypersensitivity syndrome due to cyanamide associated with multiple reactivation of human herpesviruses. J Med Virol 2005; 75: 430-434.
6. Seishima M, Yamanaka T, Fujisawa M, Tohyama M, Hashimoto K. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome. Br J Dermatol 2006; 155: 344-349.
7. Zaia JA. Viral infection associated with bone marrow transplantation. Hematol/Oncol Clin N Amer 1990; 4: 603-623.
8. Steer CB, Szer J, Sasadeusz J, Matthews JP, Beresford JA, Grigg A. Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose acyclovir and ganciclovir. Bone Marrow Transpl 2000; 25: 657-664.
9. Kano Y, Hirahara K, Sakuma K, Shiohara T. Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease. Br J Dermatol 2006; 155: 301-306.
10. Kano Y, Sakuma K, Shiohara T. Sclerodermoid graft-versushost disease-like lesions occurring after drug-induced hypersensitivity syndrome. Br J Dermatol 2007; 156: 1061-1063.
11. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 2007; 156: 1083-1084.
12. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129: 92-96.
13. Jantsch J, Schmidt B, Bardutzky J, Bogdan C, Eckardt KU, Raff U. Lethal varicella-zoster virus reactivation without skin lesions following renal transplantation. Nephrol Dial Transplant 2011; 26: 365-368.
14. Shiohara T, Kurata M, Mizukawa Y, Kano Y. Recognition of immune reconstitution syndrome necessary for better management of patients with severe drug eruption and those under immunosuppressive therapy. Allegol Int 2010; 59: 333-343.
15. Jevtovic DJ, Salemovic D, Ranin J, Pesic I, Zerjav S, Djurkovic-Djakovic O. The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy. HIV Med 2005; 6: 140-143.